Skip to main content
Published locations for Rilzabrutinib Shines in Phase 3 Trial of Tough-to-Treat Immune Thrombocytopenia
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Rilzabrutinib Shines in Phase 3 Trial of Tough-to-Treat Immune Thrombocytopenia
User login
Username
Password
Reset your password
/content/rilzabrutinib-shines-phase-3-trial-tough-treat-immune-thrombocytopenia
/content/rilzabrutinib-shines-phase-3-trial-tough-treat-immune-thrombocytopenia
/hematology-oncology/article/271872/bleeding-disorders/rilzabrutinib-shines-phase-3-trial-tough-treat-immune-thrombocytopenia